News + Filings Holdings
All
13F
13D/G
Other
|
|
Broadfin Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/23/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/22/2020 |
SC 13D/A
| Broadfin Capital, LLC reports a 6.4% stake in Strata Skin Sciences, Inc. |
| 12/23/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/18/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/04/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/08/2018 |
SC 13D/A
| Broadfin Capital, LLC reports a 10% stake in BioDelivery Sciences International, Inc. |
| 05/21/2018 |
SC 13D/A
| Broadfin Capital, LLC reports a 7.2% stake in BioDelivery Sciences International, Inc. |
| 05/01/2018 |
SC 13D/A
| Broadfin Capital, LLC reports a 7.3% stake in BioDelivery Sciences International, Inc. |
| 03/20/2018 |
SC 13D/A
| Broadfin Capital, LLC reports a 10.4% stake in Novelion Therapeutics Inc. |
| 03/15/2018 |
SC 13D/A
| Broadfin Capital, LLC reports a 11.7% stake in Recro Pharma, Inc. |
| 12/14/2017 |
SC 13D/A
| Broadfin Capital, LLC reports a 13.1% stake in Recro Pharma, Inc. |
| 12/04/2017 |
SC 13D/A
| Broadfin Capital, LLC reports a 14.2% stake in Recro Pharma, Inc. |
| 11/24/2017 |
SC 13D/A
| Broadfin Capital, LLC reports a 15.3% stake in Recro Pharma, Inc. |
| 01/13/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 12/14/2016 |
SC 13D/A
| Recro Pharma, Inc. reports a 16.4% stake in Recro Pharma, Inc. |
| 12/01/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 12/01/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 09/22/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 08/17/2016 |
SC 13D/A
| Recro Pharma, Inc. reports a 20.7% stake in Recro Pharma, Inc. |
| 03/15/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
|
|